Startups

Special report: pandemic has boosted venture dollars across health AI

After the announcement of Warren Buffett’s bet on Japan’s largest trading houses, we take a brief look at how they have been doing on the corporate venturing arena.

As the month of August draws to a close, last week we reported several initial public offerings (IPOs) which are lined up for the coming weeks along with some notable ones that have already taken place.

US-based business finance provider Kabbage, which has a host of corporates as backers, will be acquired by payment processing firm American Express.

Amid the covid-19 pandemic, interest in life sciences is now perhaps at its highest. This is true in corporate venture capital and three of the multimillion-dollar stories we reported in mid-August corroborate this.

The number of corporate-backed companies going public declined in 2019, despite some major IPOs like those of Uber, Lyft and Slack.

Over the past four quarters, almost one of every four corporate investors seems to be new, even in lockdown.

The online home insurer raised a series E round backed by a host of corporate venture investors.

Two fintech companies floated in early July 2020, giving an exit to corporate backers in what has been a good year for the sector.

Monthly analysis: June 2020

Quarterly data report: Q2 2020